Literature DB >> 6624952

Kinetics of endogenously labeled plasma fibronectin: incorporation into tissues.

D C Deno, T M Saba, E P Lewis.   

Abstract

Fibronectin exists in a soluble form in plasma and lymph as well as in a relatively insoluble form in tissues. The disappearance of endogenously labeled fibronectin from plasma and its subsequent extravascular localization was studied over a 38-h period in normal rats (350-400 g) utilizing plasma fibronectin labeled in vivo with 75Se-selenomethionine. For comparative analysis, 125I-albumin was utilized in these dual isotopic experiments. After the simultaneous injection of 75Se plasma fibronectin (20 nCi) and 125I-albumin (2 microCi), all measured tissues demonstrated accumulation of both radiolabeled proteins in extravascular sites. Plasma fibronectin demonstrated a rather specific and high affinity for liver and spleen, which are enriched with reticuloendothelial cells. Albumin manifested the expected washout from extravascular sites, whereas fibronectin primarily displayed retention in tissues. The plasma disappearance of 75Se-labeled fibronectin was well described by two exponentials: an early phase with a half time of 0.52 h and a later phase with a half time of 21 h. To account for tissue retention of labeled fibronectin, a two-compartment kinetics model was required that included loss from the extravascular exchangeable compartment. Analysis of the disappearance kinetics and fibronectin distribution allowed estimation of the fractional turnover rate, pool size, and mean residence time. Accordingly the total rate of loss for plasma fibronectin was 0.51-0.54 mg/h. The calculated pool size of the soluble form of fibronectin was 15.5-16.3 mg. The mean residence time for exchangeable fibronectin was 29.6-29.9 h. These findings suggest that plasma fibronectin can be incorporated within the insoluble pool of fibronectin in tissues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6624952     DOI: 10.1152/ajpregu.1983.245.4.R564

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Plasma fibronectin and complement following infusion of colloidal solutions after spinal anaesthesia.

Authors:  J M Vedrinne; J P Hoen; D Bussery; C Veyssere; M Richard; J Motin
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Regulation of p38 MAP kinase by anastellin is independent of anastellin's effect on matrix fibronectin.

Authors:  Ran You; R Matthew Klein; Mingzhe Zheng; Paula J McKeown-Longo
Journal:  Matrix Biol       Date:  2009-02-04       Impact factor: 11.583

3.  Quantification of tissue fibronectin from terminal villi of placenta.

Authors:  B A Bray
Journal:  Biochem J       Date:  1985-03-15       Impact factor: 3.857

Review 4.  Pulmonary edema: current concepts of pathophysiology, clinical significance, and methods of measurement.

Authors:  R H Demling
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

5.  Influence of barrier-crossing limitations on the amount of macromolecular drug taken up by its target.

Authors:  A Aubrée-Lecat; M C Duban; S Demignot; M Domurado; P Fournié; D Domurado
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

6.  Lung vascular injury with protease infusion. Relationship to plasma fibronectin.

Authors:  L F Cohler; T M Saba; E P Lewis
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

7.  Cryptic activity within the Type III1 domain of fibronectin regulates tissue inflammation and angiogenesis.

Authors:  Christina Cho; Rhiannon Kelsh-Lasher; Anthony Ambesi; Paula J McKeown-Longo
Journal:  Curr Top Pept Protein Res       Date:  2015

8.  Human fibronectin metabolism.

Authors:  B A Pussell; P W Peake; M A Brown; J A Charlesworth
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Mechanism of acute depletion of plasma fibronectin following thermal injury in rats. Appearance of a gelatinlike ligand in plasma.

Authors:  D C Deno; M H McCafferty; T M Saba; F A Blumenstock
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

10.  Leukocyte elastase-independent proteolysis of gelatin-bound fibronectin by inflammatory macrophages.

Authors:  I Daudi; P W Gudewicz; T M Saba; E Cho; M B Frewin
Journal:  Inflammation       Date:  1991-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.